Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Capromab - Cytogen Corporation

Drug Profile

Capromab - Cytogen Corporation

Alternative Names: 111In CYT 356; Capromab pendetide; CYT 356; indium (111In) labeled capromab pendetide; Indium-111-CYT-356; lndium-CYT-356; ProstaScint

Latest Information Update: 24 Mar 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cytogen Corporation
  • Class Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics
  • Mechanism of Action Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Prostate cancer

Most Recent Events

  • 22 Mar 2021 Neos Therapeutics has merged with Aytu BioScience to form Aytu BioPharma
  • 01 Apr 2019 Hybridyne Imaging Technologies completes a clinical trial in Prostate cancer (Diagnosis) in Canada (NCT02786459)
  • 06 Jun 2016 Hybridyne Imaging Technologies initiates enrolment in a clinical trial in Prostate cancer (Diagnosis) in Canada
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top